PARP Inhibitor Treatment in Ovarian and Breast Cancer

被引：131
作者：
不详
机构：
来源：
CURRENT PROBLEMS IN CANCER | 2011年 / 35卷 / 01期
关键词：
POLY(ADP-RIBOSE) POLYMERASE-1 INHIBITOR; GENE-EXPRESSION; DNA-DAMAGE; SPORADIC BREAST; MISMATCH-REPAIR; HOMOLOGOUS RECOMBINATION; ATAXIA-TELANGIECTASIA; PROTEIN-KINASE; STRAND BREAKS; MUTANT-CELLS;
D O I：
10.1016/j.currproblcancer.2010.12.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：7 / 50
页数：44
相关论文
共 130 条
[81]   Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors [J].
Mendes-Pereira, Ana M. ;
Martin, Sarah A. ;
Brough, Rachel ;
McCarthy, Afshan ;
Taylor, Jessica R. ;
Kim, Jung-Sik ;
Waldman, Todd ;
Lord, Christopher J. ;
Ashworth, Alan .
EMBO MOLECULAR MEDICINE, 2009, 1 (6-7) :315-322
[82]   The selective poly(ADP-ribose) polymerase-1(2) inhibitor, CEP-8983, increases the sensitivity of chemoresistant tumor cells to temozolomide and irinotecan but does not potentiate myelotoxicity [J].
Miknyoczki, Sheila ;
Chang, Hong ;
Grobelny, Jennifer ;
Pritchard, Sonya ;
Worrell, Candace ;
McGann, Natalie ;
Ator, Mark ;
Husten, Jean ;
Deibold, James ;
Hudkins, Robert ;
Zulli, Allison ;
Parchment, Ralph ;
Ruggeri, Bruce .
MOLECULAR CANCER THERAPEUTICS, 2007, 6 (08) :2290-2302
[83]  
Miknyoczki SJ, 2003, MOL CANCER THER, V2, P371
[84]   PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis [J].
Muñoz-Gámez, JA ;
Martín-Oliva, D ;
Aguilar-Quesada, R ;
Cañuelo, A ;
Nuñez, MI ;
Valenzuela, MT ;
De Almodóvar, JMR ;
De Murcia, G ;
Oliver, FJ .
BIOCHEMICAL JOURNAL, 2005, 386 :119-125
[85]  
*NIH, 2010, BREAST CANC
[86]  
O'Shaughnessy J, 2010, ANN ONCOL, V21, P5
[87]  
OSFRAUGHNESSY J, 2009, J CLIN ONCOL, V27
[88]  
OSHAUGHNESSY J, 2008, SAN ANT BREAST CANC
[89]  
Plummer R, 2006, J CLIN ONCOL, V24, p456S
[90]  
RAJAN A, 2010, TAT
45678910111213